nct02637284 bpc-157 status results PDF) Emerging Use of in Orthopaedic Sports Medicine: A Systematic Review Stable gastric pentadecapeptide BPC 157

V.HabashiN.McCunnM.ShihD.McQuillanK.et al (2007)

People report a decrease in their appetite, an increase in their metabolism, a loss of inches and/or pounds, more energy, and other benefits

Identity confirmation by mass spectrometry, purity assay, appearance check, and moisture content

It is indicated for anorexia, fatigue and debility conditions

Regulatory Approval by the TGA Once clinical trials are successfully completed, the treatment developer, also known as the sponsor, will use its scientifically robust data regarding the medicines quality, safety and efficacy, to apply for registration from the Therapeutic Goods Administration (TGA), Australias regulatory authority for therapeutic goods

You are generally healthy with no underlying digestive or absorption issues